The consulting firm’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
Via https://www.nytimes.com/2022/04/27/business/mckinsey-congress-opioids.html
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
April 2023
Categories |